Premium
Cardiac biomarkers in neonatal hypoxic ischaemia
Author(s) -
Sweetman D,
Armstrong K,
Murphy JFA,
Molloy EJ
Publication year - 2012
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2011.02539.x
Subject(s) - medicine , troponin , cardiology , ischemia , natriuretic peptide , cardiac function curve , hypoxia (environmental) , myocardial ischaemia , intensive care medicine , myocardial infarction , heart failure , chemistry , organic chemistry , oxygen
Following a perinatal hypoxic–ischaemic insult, term infants commonly develop cardiovascular dysfunction. Troponin‐T, troponin‐I and brain natriuretic peptide are sensitive indicators of myocardial compromise. The long‐term effects of cardiovascular dysfunction on neurodevelopmental outcome following perinatal hypoxic ischaemia remain controversial. Follow‐up studies are warranted to ensure optimal cardiac function in adulthood. Conclusion: Cardiac biomarkers may improve the diagnosis of myocardial injury, help guide management, estimate mortality risk and may also aid in longterm neurodevelopmental outcome prediction following neonatal hypoxic‐ischaemia.